UFPT UFP Technologies

UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL

UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL

NEWBURYPORT, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (UFPT), today announced Mitch Rock, President, and Ron Lataille, Sr. VP and CFO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 26, 2025, at The InterContinental in Chicago, IL. UFP’s presentation is scheduled to begin at 7:55 AM CT. The presentation is webcast and can be accessed through the conference host’s main website: and in the Investor Relations section of the company's website: .

About IDEAS Investor Conferences

The mission of the IDEAS Conferences is to provide independent regional venues for quality companies to present their investment merits to an influential audience of investment professionals. Unlike traditional bank-sponsored events, IDEAS Investor Conferences are “SPONSORED BY INVESTORS. FOR INVESTORS.” and for the benefit of regional investment communities. Conference sponsors collectively have more than $200 billion in assets under management and include: 1102 Partners, Adirondack Research and Management, Allianz Global Investors: NFJ Investment Group, Ariel Investments, Aristotle Capital Boston, Ascend Wealth Advisors, Barrow Hanley Mewhinney & Strauss, BMO Global Asset Management, Constitution Research & Management, Inc., Diamond Hill, First Wilshire Securities Management, Inc., Granahan Investment Management, Great Lakes Advisors, Greenbrier Partners Capital Management, LLC, Hodges Capital Management, Ironwood Investment Management, Keeley Teton Advisors, Luther King Capital Management, Marble Harbor Investment Counsel, North Star Investment Management, Perritt Capital Management, Punch & Associates, Shepherd Kaplan Krochuk, Westwood Holdings Group, Inc., and William Harris Investors.

The IDEAS Investor Conferences are held annually and are produced by Three Part Advisors, LLC. Additional information about the events can be located at .

If interested in participating or learning more about the IDEAS conferences, please contact Lacey Wesley at (817) 769 -2373 or .

About UFP Technologies, Inc.

UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.

Contacts:

Ron Lataille, CFO, UFP Technologies, Inc., tel. 978-234-0926

   

Jeff Elliott, Three Part Advisors, LLC, tel. 214-966-9014



EN
20/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on UFP Technologies

UFP Technologies Inc: 1 director

A director at UFP Technologies Inc sold 1,829 shares at 227.201USD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

UFP Technologies Announces Strong Q3 2025 Results

UFP Technologies Announces Strong Q3 2025 Results NEWBURYPORT, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $16.4 million or $2.11 per diluted common share outstanding for its third quarter ended September 30, 2025, the same as in Q3 of 2024. Adjusted earnings per diluted share outstanding for the third quarter ended September 30, 2025, was $2.39. Sales for the third quarter were $154.6 million compared to ...

 PRESS RELEASE

UFP Technologies to Report Third Quarter 2025 Financial Results on Nov...

UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025 Conference Call Scheduled for November 4th at 8:30 AM ET NEWBURYPORT, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the third quarter on Monday, November 3rd, after the close of the stock market. The Company will hold a conference call to discuss the results on the following day, November 4th...

 PRESS RELEASE

UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th...

UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL NEWBURYPORT, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (UFPT), today announced Mitch Rock, President, and Ron Lataille, Sr. VP and CFO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 26, 2025, at The InterContinental in Chicago, IL. UFP’s presentation is scheduled to begin at 7:55 AM CT. The presentation is webcast and can be accessed through the conference host’s main website: and in the Investor Rel...

 PRESS RELEASE

UFP Technologies Announces Record Q2 Results

UFP Technologies Announces Record Q2 Results NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its second quarter ended June 30, 2025, compared to net income of $13.6 million or $1.75 per diluted common share outstanding for the same quarter in 2024. Adjusted earnings per diluted common share outstanding grew 27% to $2.50. Sales for the second quarter were $...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch